Sex-specific Association of Chronic Proton Pump Inhibitor Use With Reduced Bone Density and Quality

被引:0
|
作者
Bioletto, Fabio [1 ]
Pusterla, Alessia [1 ]
Fraire, Federica [1 ]
Sauro, Lorenzo [1 ]
Presti, Michela [2 ]
Arvat, Emanuela [2 ]
Ghigo, Ezio [1 ]
Procopio, Massimo [1 ]
Barale, Marco
机构
[1] Univ Turin, Dept Med Sci, Div Endocrinol Diabet & Metab, Corso Dogliotti 14, I-10126 Turin, Italy
[2] Univ Turin, Dept Med Sci, Div Oncol Endocrinol, I-10126 Turin, Italy
关键词
proton pump inhibitors; PPI; osteoporosis; bone density; bone quality; trabecular bone score; MINERAL DENSITY; HIP FRACTURE; RISK; OSTEOPOROSIS; THERAPY; MEDICATIONS; SCORE; EXPRESSION; MAGNESIUM; DISEASES;
D O I
10.1210/clinem/dgae598
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Chronic use of proton pump inhibitors (PPIs) has been associated with an increase in bone fragility. However, evidence on the effect of chronic PPI use on bone density is conflicting, and data on bone microarchitectural quality are scarce. Objective: The primary aim of this study was to evaluate whether trabecular bone microarchitecture, assessed by trabecular bone score (TBS), is altered in chronic PPI users. The association between PPI use and bone density was also evaluated as a secondary endpoint. Methods: We extracted individual patient data from the 2005 to 2008 cycles of the population-based National Health and Nutrition Examination Survey (NHANES), in which lumbar spine dual-energy X-ray absorptiometry scans were acquired. TBS values were calculated from dual-energy X-ray absorptiometry images using a dedicated software. Multivariable linear regression analyses stratified by sex were performed to evaluate the association of chronic PPI use with TBS and bone mineral density (BMD), adjusting for relevant confounders. Results: A total of 7478 subjects were included (3961 men, 3517 women). After adjustment for relevant confounders, chronic PPI use was associated with a worse bone health profile in men, with lower TBS (-0.039; 95% CI, -0.058 to -0.020; P < .001), lumbar spine T-score (-0.27; 95% CI, -0.51 to -0.04; P = .023), total hip T-score (-0.21; 95% CI, -0.41 to -0.01; P = .041), and femoral neck T-score (-0.22; 95% CI, -0.44 to -0.00; P = .047). Notably, the association between chronic PPI use and degraded TBS remained statistically significant even after further adjustment for BMD at lumbar spine and femoral neck (-0.026; 95% CI, -0.039 to -0.012; P = .001). In contrast, no significant association was observed between chronic PPI use and either TBS or BMD in women. Conclusion: Chronic PPI use is associated with degraded trabecular bone quality in men, even after adjustment for BMD. No association was observed in women.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] The Association Between Prolonged Proton Pump Inhibitors Use and Bone Mineral Density
    Fattahi, Mohammad Reza
    Niknam, Ramin
    Shams, Mesbah
    Anushiravani, Amir
    Taghavi, Seyed Alireza
    Omrani, Gholamhossein Ranjbar
    Mahmoudi, Laleh
    RISK MANAGEMENT AND HEALTHCARE POLICY, 2019, 12 : 349 - 355
  • [2] Proton pump inhibitor use and bone fractures in patients with chronic kidney disease
    Kommer, Andreas
    Kostev, Karel
    Schleicher, Eva Maria
    Weinmann-Menke, Julia
    Labenz, Christian
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, : 173 - 181
  • [3] Use of proton pump inhibitors is associated with lower trabecular bone density in older individuals
    Maggio, Marcello
    Lauretani, Fulvio
    Ceda, Gian Paolo
    De Vita, Francesca
    Bondi, Giuliana
    Corsonello, Andrea
    Cattabiani, Chiara
    Lattanzio, Fabrizia
    Ruggiero, Carmelinda
    Nouvenne, Antonio
    Meschi, Tiziana
    Bandinelli, Stefania
    Ferrucci, Luigi
    BONE, 2013, 57 (02) : 437 - 442
  • [4] Proton-Pump Inhibitor Use Is Not Associated With Osteoporosis or Accelerated Bone Mineral Density Loss
    Targownik, Laura E.
    Lix, Lisa M.
    Leung, Stella
    Leslie, William D.
    GASTROENTEROLOGY, 2010, 138 (03) : 896 - 904
  • [5] The Association Between Proton Pump Inhibitor Use With Acute Kidney Injury and Chronic Kidney Disease
    Kamal, Faisal
    Khan, Muhammad A.
    Molnar, Miklos Z.
    Howden, Colin W.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2018, 52 (06) : 468 - 476
  • [6] Proton pump inhibitors use and change in bone mineral density
    Arj, Abbas
    Zade, Mohsen Razavi
    Yavari, Maryam
    Akbari, Hossein
    Zamani, Batol
    Asemi, Zatollah
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2016, 19 (09) : 864 - 868
  • [7] Do patients with gastroesophageal reflux disease exhibit compromised bone quality prior to proton pump inhibitor therapy?
    Aasarod, Kristin M.
    Mosti, Mats P.
    Finstad, Malin T.
    Stunes, Astrid K.
    Fossmark, Reidar
    Syversen, Unni
    BONE REPORTS, 2021, 14
  • [8] Bone mineral density variation in men is influenced by sex-specific and non sex-specific quantitative trait loci
    Peacock, Munro
    Koller, Daniel L.
    Lai, Dongbing
    Hui, Siu
    Foroud, Tatiana
    Econs, Michael J.
    BONE, 2009, 45 (03) : 443 - 448
  • [9] Effects of Prolonged Proton-Pump Inhibitor Use on Renal Dysfunction and Bone Fragility: A Retrospective Study
    Protopapadakis, Yianni
    Shuster, Hayden
    Bambach, Austin B.
    Fitzgerald, Sean
    Brayman, Christian
    Ewing, Joseph A.
    Blumer, Mary
    ANNALS OF PHARMACOTHERAPY, 2025, 59 (04) : 330 - 336
  • [10] Sex-specific factors for bone density in patients with schizophrenia
    Lin, Chieh-Hsin
    Lin, Chun-Yuan
    Huang, Tiao-Lai
    Wang, Hong-Song
    Chang, Yue-Cune
    Lane, Hsien-Yuan
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2015, 30 (02) : 96 - 102